0GZX.L - DiaSorin S.p.A.
LSE - LSE Prezzo differito. Valuta in EUR.
Alla chiusura: 05:10PM BST
Il grafico dei titoli non è supportato dal tuo browser attuale
| Chiusura precedente | 134,39 |
| Aperto | 134,07 |
| Denaro | N/D x N/D |
| Lettera | N/D x N/D |
| Min-Max giorno | 131,40 - 138,60 |
| Intervallo di 52 settimane | 131,40 - 138,60 |
| Volume | |
| Media Volume | N/D |
| Capitalizzazione | N/D |
| Beta (5 anni mensile) | 0,13 |
| Rapporto PE (ttm) | N/D |
| EPS (ttm) | N/D |
| Prossima data utili | N/D |
| Rendimento e dividendo (forward) | N/D (N/D) |
| Data ex dividendo | N/D |
| Stima target 1A | N/D |
GlobeNewswireCytek® Biosciences to Acquire Flow Cytometry and Imaging Business from DiaSorin
Sale of assets related to Flow Cytometry & Imaging (FCI) Business UnitAcquisition will expand Cytek’s product portfolio to include imaging and menu-based application driven flow cytometry to provide full cell analysis solutions to its customersTransaction is in line with DiaSorin’s strategic priorities communicated to the market after Luminex acquisitionEmployees associated with commercial, operations, R&D and supporting functions expected to join Cytek SALUGGIA, Italy and FREMONT, Calif., Feb.